Skip to main content

Table 2 Van Tulder Score and patient characteristics

From: Motor training programs of arm and hand in patients with MS according to different levels of the ICF: a systematic review

Reference

Tulder

LOE

Design

Patients

Interv CG

 

int val

descr

stat

total

  

MS type

EDSS

Age

TSFS

TSLE at least

EG (n)

CG (n)

 

Gehlsen et al. [24]

2

3

2

7

C

CS

?

?

40.2

?

?

10

no

 

Romberg et al. [21, 22]

5

6

2

13

B

RCT

?

1-5.5

44 (7.1)

6 (0–23)

1 mo

47

48

no

Taylor al. [25]

5

4

2

11

C

CS

?

0-6.5

45.6 (27–61)

6 (1–13)*

1 mo

12

no

 

Freeman et al. [26]

4

4

2

10

B

RCT

SP,PP

5-9.5

43 (25–73)

15.4 (3–32)

1 mo

32

34

WL

Khan et al. [33]

9

5

2

16

A2

RCT

RR, SP,PP

0-8

49.5 (30–63)

10.7 (6.3)*

3 mo

48

50

WL (maint)

Mark et al. [27]

3

4

2

9

C

Pilot

PP, SP

6-7

56 (50–60)

?

3 mo

5

no

 

Patti et al. [28]

7

6

2

15

A2

RCT

SP,PP

4-8

25-60

1.5 (0.5-2.5)

3 mo

58

53

home exerc.

Jones et al. [29]

2

4

1

7

B

CCT

moderate to severe ataxia and PP, SP

?

36.9 (8.2)

?

1 year

28

9

WL

Mathiowetz et al. [30]

3

4

2

9

C

CS

B, RR,PP, SP

2.5-8

45 (27–63)

12 (1–27)

?

30

no

 

Storr et al. [31]

6

4

2

12

B

RCT

P, S, RR

0-9

53 (33–66)

15 (3–45)

3 mo

38

52

WL

Vikman et al. [32]

4

4

2

10

C

CS/CCT**

RR,SP,PP

4-6.5

55.8 (10.3)

18.3 (2–43)

?

40 + 18

18

WL

  1. B (Benign); CG (Control Group); CS (Case Series); CCT (Controlled Clinical Trial); Descr (Descriptive score); EDSS (Expanded Disability Status Scale); EG (Experimental Group); Interv CG (Intervention Control Group); Int Val (internal Validity); LOE (Level of Evidence); P (Progressive); maint. (maintenance); mo (months) PP (Primary Progressive); RR (Relapse Remitting); RCT (Randomised Controlled Trial); S (Secondary); SP (Secondary Progressive); TSFS (time Since First Symptoms); TSLE (time since last exacerbation); WL (Waiting List); ? (not specified); *(Time since diagnosis); **(CCT for 18 persons).